Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

RTI agrees to supply Stryker with spinal allograft implants

Regeneration Technologies : 25 June, 2007  (New Product)
Regeneration Technologies (RTI) has signed an agreement to provide Stryker, one of the world's leading medical technology companies, with spinal allograft implants.
Under the agreement, which is effective immediately, RTI will process cervical spinal grafts from designs developed by Stryker.

'We are pleased to work with Stryker to deliver more sterilized spinal implants to surgeons', said Brian K Hutchison, RTI's chairman, president and chief executive officer.

'Working together, Stryker and RTI can bring biologic alternatives to patients while working to maximize each gift of donated tissue'.

'We are excited to be working with Regeneration Technologies and pleased that this relationship will allow us to better serve our customer's allograft needs' said Timothy J Scannell, president of Stryker's Spine division.

RTI processes allograft and xenograft tissue into shaped implants for use in orthopaedic and other surgeries with a commitment to science, safety and innovation.

RTI also holds the patents on BioCleanse, the only proven tissue sterilization process validated to eliminate viruses, bacteria, fungi and spores from tissue without impacting the structural or biomechanical integrity of the tissue.

The company has distributed more than half a million allograft implants sterilized with the BioCleanse process with zero incidence of infection.

RTI is accredited by the American Association of Tissue Banks.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo